| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 41.10B | 17.22B | 25.27B | 44.70B | 64.45B | 60.60B | 
| Gross Profit | 23.35B | 17.22B | 25.27B | 44.70B | 64.45B | 60.60B | 
| EBITDA | 5.22B | 5.93B | 4.00B | 3.72B | 4.74B | 3.82B | 
| Net Income | 3.86B | 4.07B | 2.87B | 3.73B | 3.26B | 3.08B | 
| Balance Sheet | ||||||
| Total Assets | 814.84B | 802.16B | 713.23B | 701.46B | 630.49B | 600.49B | 
| Cash, Cash Equivalents and Short-Term Investments | 25.54B | 24.71B | 19.38B | 18.84B | 17.23B | 7.95B | 
| Total Debt | 9.29B | 10.23B | 9.65B | 11.29B | 9.73B | 10.71B | 
| Total Liabilities | 782.15B | 771.01B | 683.38B | 669.14B | 600.00B | 573.48B | 
| Stockholders Equity | 29.54B | 29.54B | 26.84B | 29.01B | 27.22B | 24.03B | 
| Cash Flow | ||||||
| Free Cash Flow | 4.28B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B | 
| Operating Cash Flow | 4.28B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B | 
| Investing Cash Flow | -103.00M | -408.00M | -786.00M | -5.49B | -11.21B | -8.20B | 
| Financing Cash Flow | -2.71B | -2.29B | -3.55B | -620.00M | -992.00M | 2.01B | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | C$54.74B | 14.79 | 14.19% | 4.05% | 15.27% | 4.72% | |
| ― | C$54.15B | 7.96 | 18.70% | 0.96% | 16.79% | 20.82% | |
| ― | C$15.08B | 15.12 | 13.43% | 2.26% | -4.55% | 42.41% | |
| ― | C$39.03B | 14.13 | 12.07% | 4.41% | 11.56% | 1.15% | |
| ― | $48.43B | 15.43 | 13.38% | 3.99% | -0.61% | 6.69% | |
| ― | $77.76B | 14.67 | 11.57% | 3.79% | 9.37% | 32.06% | |
| ― | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | 
Great-West Lifeco Inc. will release its third quarter 2025 financial results after market close on November 5, with a conference call scheduled for November 6 to discuss the results. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning in the financial services industry.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$53.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco has successfully completed its offering of 8 million Series Z Preferred Shares, raising $200 million in gross proceeds. The shares, which will trade on the Toronto Stock Exchange under the symbol GWO.PR.Z, were offered through a syndicate of underwriters led by BMO Capital Markets, RBC Capital Markets, and Scotiabank. This move is expected to strengthen Great-West Lifeco’s financial position and enhance its market presence.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$59.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco announced an agreement with a syndicate of underwriters to issue 6,000,000 Non-Cumulative First Preferred Shares, Series Z, at C$25.00 per share, raising C$150 million. The offering, which may increase to C$200 million if an option to purchase additional shares is exercised, is intended for general corporate purposes and is expected to close on or about September 24, 2025. This move is part of Lifeco’s strategy to strengthen its financial position and enhance its market presence in the financial services industry.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$56.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco Inc. announced that Edmund F. Murphy, President and CEO of Empower, will participate in a virtual fireside chat with TD Cowen’s Senior Equity Analyst, William Katz, on September 15, 2025. This event highlights the company’s engagement with financial analysts and stakeholders, potentially impacting its market visibility and investor relations.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$62.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco has appointed John Melvin as Chief Investment Officer, effective October 1, 2025. With over 30 years of investment experience, Melvin will focus on enhancing investment capabilities and identifying new growth opportunities, reflecting the company’s commitment to strengthening its leadership and supporting strategic objectives.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$62.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco Inc. announced amendments to its normal course issuer bid (NCIB), increasing the maximum number of common shares that can be repurchased from 20 million to 40 million. The Toronto Stock Exchange approved an amendment allowing Lifeco to purchase shares from Power Financial Corporation to maintain its proportionate interest. This move supports Lifeco’s strategic plan to repurchase an additional $500 million in shares in 2025, enhancing shareholder value and maintaining market stability.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$62.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco announced that its Executive Vice President and Chief Financial Officer, Jon Nielsen, will present at the Barclays Global Financial Services Conference on September 8, 2025. This participation highlights the company’s active engagement in the financial services industry and may provide insights into its strategic direction and financial outlook.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$62.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco announced that its President and CEO, David Harney, will speak at the Scotiabank Financials Summit on September 4, 2025. This engagement highlights the company’s active participation in industry events, potentially enhancing its visibility and influence within the financial sector.
The most recent analyst rating on (TSE:GWO) stock is a Buy with a C$62.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.
Great-West Lifeco’s recent earnings call painted a picture of robust financial health and strategic execution, marked by record base earnings and substantial growth in key segments like Empower and Group Benefits. Despite some challenges, such as the exit from the U.S. traditional life reinsurance market and credit-related impacts, the overall sentiment was positive, underscoring the company’s solid financial standing.
Great-West Lifeco Inc. reported record base earnings of over $1.1 billion for Q2 2025, marking an 11% increase from the previous year, driven by strong performance in its wealth and group benefits businesses. Despite a decline in net earnings due to business transformation charges and market challenges, the company plans an additional $500 million in share buybacks, reflecting its strong capital position and focus on growth strategies.
The most recent analyst rating on (TSE:GWO) stock is a Hold with a C$54.00 price target. To see the full list of analyst forecasts on Great-West Lifeco stock, see the TSE:GWO Stock Forecast page.